13F filer · CIK 1842545
Eagle Health Investments LP
Greenwich, CT · filing since Q4 2020 · last filing Aug 10, 2026
Reported value
$603.3M
+$31.5M vs prior
Positions
27
New / sold out
6 / 7
Added / reduced
9 / 4
Turnover
21.1%
buys $123.8M · sells $218.7M
Top-10 weight
66.1%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ASCENDIS PHARMA A/S | +106,158 | – | +$28.3M |
| Added | INSMED INC | +159,859 | +71.3% | +$17.0M |
| New | AXSOME THERAPEUTICS INC. | +65,051 | – | +$15.9M |
| New | IONIS PHARMACEUTICALS INC | +194,577 | – | +$15.4M |
| New | DIANTHUS THERAPEUTICS INC | +131,344 | – | +$12.8M |
| Added | PROTAGONIST THERAPEUTICS INC | +69,000 | +38.5% | +$8.5M |
| Added | BIOMARIN PHARMACEUTICAL INC | +118,867 | +23.5% | +$6.8M |
| New | AVALO THERAPEUTICS INC | +235,093 | – | +$4.3M |
| Added | SCHOLAR ROCK HLDG CORP | +61,253 | +12.4% | +$3.4M |
| Added | BOSTON SCIENTIFIC CORP | +76,012 | +25.9% | +$3.2M |
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | SPDR SERIES TRUSTPUT | -730,000 | -100.0% | $-93.2M |
| Reduced | NATERA INC | -106,030 | -87.0% | $-28.8M |
| Sold out | TERNS PHARMACEUTICALS INC | -412,497 | -100.0% | $-21.7M |
| Sold out | BRIDGEBIO PHARMA INC | -267,031 | -100.0% | $-19.8M |
| Sold out | ASCENDIS PHARMA A/S | -86,650 | -100.0% | $-19.8M |
| Sold out | PROCEPT BIOROBOTICS CORP | -483,815 | -100.0% | $-12.1M |
| Reduced | ICON PUB LTD CO | -50,357 | -14.0% | $-8.7M |
| Sold out | CENTESSA PHARMACEUTICALS PLC | -214,291 | -100.0% | $-8.5M |
| Sold out | PROCEPT BIOROBOTICS CORPCALL | -90,000 | -100.0% | $-2.3M |
| Reduced | FORTREA HLDGS INC | -126,286 | -9.7% | $-2.2M |
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ARGENX SESPONSORED ADR | 76,417 | $70.9M | 11.75% |
| 2 | ICON PUB LTD COSHS | 308,143 | $53.5M | 8.87% |
| 3 | GUARDANT HEALTH INCCOM | 300,685 | $45.1M | 7.48% |
| 4 | INSMED INCCOM PAR $.01 | 384,130 | $41.0M | 6.79% |
| 5 | BIOMARIN PHARMACEUTICAL INCCOM | 624,676 | $35.7M | 5.92% |
| 6 | ILLUMINA INCCOM | 187,413 | $33.0M | 5.46% |
| 7 | SCHOLAR ROCK HLDG CORPCOM | 555,272 | $30.5M | 5.06% |
| 8 | PROTAGONIST THERAPEUTICS INCCOM | 248,322 | $30.4M | 5.05% |
| 9 | ULTRAGENYX PHARMACEUTICAL INCOM | 884,121 | $29.5M | 4.89% |
| 10 | COMPASS PATHWAYS PLCSPONSORED ADS | 2,060,427 | $29.2M | 4.83% |
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.